(Q37670250)

21 August 2017

1 reference

title

TGF-beta signalling and immunity in prostate tumourigenesis (English)

1 reference

21 August 2017

John D Hayball

4

0 references

Kerrilyn R Diener

object named as

Kerrilyn R Diener

series ordinal

1

1 reference

ORCID Public Data File 2021

author name string

Eleanor F Need

series ordinal

2

1 reference

21 August 2017

Grant Buchanan

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Therapeutic Targets

21 August 2017

published in

1 reference

21 August 2017

volume

14

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

179-192

1 reference

Immunomodulation by human seminal plasma: a benefit for spermatozoon and pathogen?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Transforming growth factor beta--a mediator of immune deviation in seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Role of transforming growth factor-beta1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Molecular genetics of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Classics in oncology. On the frequency of occurrence of occult carcinoma of the prostate: Arnold Rice Rich, M.D., Journal of Urology 33:3, 1935.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Stroma-epithelium crosstalk in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Regulation of prostate branching morphogenesis by activin A and follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The loss of TGF-beta signaling promotes prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Hic-5/ARA55: a prostate stroma-specific AR coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Isolation and functional characterization of murine prostate stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Generation of a prostate from a single adult stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

A luminal epithelial stem cell that is a cell of origin for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Control of type II transforming growth factor-beta receptor expression by integrin ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Models, mechanisms and clinical evidence for cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Advances in prostate cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Dendritic cells in a mature age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Transforming growth factor-β-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Coronary vessel development is dependent on the type III transforming growth factor beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

The TGFBeta pathway as a therapeutic target in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903544507

10.1517/14728220903544507

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference